v3.26.3
CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders' Equity
Total Shareholders' Equity
Stock Options and Stock Appreciation Rights
Total Shareholders' Equity
Performance Shares
Total Shareholders' Equity
Restricted Stock Units
Common Stock
Common Stock
Stock Options and Stock Appreciation Rights
Common Stock
Performance Shares
Common Stock
Restricted Stock Units
Additional Paid-In Capital
Additional Paid-In Capital
Stock Options and Stock Appreciation Rights
Additional Paid-In Capital
Performance Shares
Additional Paid-In Capital
Restricted Stock Units
Retained Earnings
Treasury Shares- at Cost
Treasury Shares- at Cost
Stock Options and Stock Appreciation Rights
Treasury Shares- at Cost
Performance Shares
Treasury Shares- at Cost
Restricted Stock Units
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Jun. 30, 2025           37,868                          
Beginning balance at Jun. 30, 2025   $ 1,844,520       $ 10,000       $ 198,970       $ 2,447,931 $ (720,695)       $ (91,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net income $ 100,807 100,807                       100,807          
Other comprehensive loss (1,889) (1,889)                                 (1,889)
Purchases of common stock for treasury (in Shares)           (204)                          
Purchases of common stock for treasury   (53,566)                         (53,566)        
Treasury shares issued for:                                      
Exercise of stock appreciation rights (in shares)             15                        
Additional Paid in Capital, Exercise of stock appreciation rights, Performance share awards, Restricted stock units                     $ (1,098) $ (1,942) $ (1,013)            
Exercise of stock appreciation rights                               $ (1,270)      
Treasury shares issued for total shareholders' equity     $ (2,368) $ (4,847) $ (2,145)                            
Performance share awards (in shares)               25                      
Performance share awards                                 $ (2,905)    
Restricted stock units (in shares)                 14                    
Restricted stock units                                   $ (1,132)  
Compensation expense   1,831 1,494             1,831 1,494                
Other (in shares)           0                          
Other   (82)               (1)       53 (134)        
Ending balance (in shares) at Sep. 30, 2025           37,718                          
Ending balance at Sep. 30, 2025   1,883,755       $ 10,000       198,241       2,548,791 (779,702)       (93,575)
Beginning balance (in shares) at Jun. 30, 2026           36,803                          
Beginning balance at Jun. 30, 2026 1,861,749 1,861,749       $ 10,000       204,606       2,788,709 (1,046,770)       (94,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net income 110,403 110,403                       110,403          
Other comprehensive loss (2,353) (2,353)                                 (2,353)
Purchases of common stock for treasury (in Shares)           (245)                          
Purchases of common stock for treasury   (80,692)                         (80,692)        
Treasury shares issued for:                                      
Exercise of stock appreciation rights (in shares)             18                        
Additional Paid in Capital, Exercise of stock appreciation rights, Performance share awards, Restricted stock units                     (1,767) $ (1,107) $ (1,188)            
Exercise of stock appreciation rights                               $ (1,870)      
Treasury shares issued for total shareholders' equity     (3,637) $ (2,643) $ (2,406)                            
Performance share awards (in shares)               10                      
Performance share awards                                 $ (1,536)    
Restricted stock units (in shares)                 12                    
Restricted stock units                                   $ (1,218)  
Compensation expense   2,102 $ 1,767             2,102 $ 1,767                
Other   26       $ 1       (14)       25 15        
Ending balance (in shares) at Sep. 30, 2026           36,599                          
Ending balance at Sep. 30, 2026 $ 1,884,316 $ 1,884,316       $ 10,000       $ 204,399       $ 2,899,137 $ (1,132,071)       $ (97,149)